Please use this identifier to cite or link to this item: https://etd.cput.ac.za/handle/20.500.11838/2239
DC FieldValueLanguage
dc.contributor.advisorDavison, Glenda Maryen
dc.contributor.advisorBellairs, Gregen
dc.contributor.advisorBird, Arthuren
dc.contributor.authorPeters, Yvonne Grace-
dc.date.accessioned2016-04-20T08:22:11Z-
dc.date.accessioned2016-09-15T09:27:22Z-
dc.date.available2016-04-20T08:22:11Z-
dc.date.available2016-09-15T09:27:22Z-
dc.date.issued2015-
dc.identifier.urihttp://hdl.handle.net/20.500.11838/2239-
dc.descriptionThesis (MTech (Biomedical Sciences))--Cape Peninsula University of Technology, 2015.en_US
dc.description.abstractPrevious international studies have documented a marked variation in transfusion practice for Total Hip Replacement (THR) surgery. This is despite widespread dissemination of clinical guidelines for the use of blood products. The cost and potential wastage of blood products as well as concerns regarding patient care and outcomes are important drivers of optimal blood management. The aim of this study was to audit red cell product utilisation for THR surgeries at two tertiary referral hospitals.en_US
dc.language.isoenen_US
dc.publisherCape Peninsula University of Technologyen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/za/en
dc.subjectTotal hip replacementen_US
dc.subjectBlood -- Transfusionen_US
dc.subjectErythrocytesen_US
dc.titleA clinical audit of the utilisation of red blood cell products in elective total hip replacement surgeryen_US
dc.typeThesisen_US
Appears in Collections:Biomedical Technology - Masters Degrees
Files in This Item:
File Description SizeFormat 
195071883_Peters_YG_MTech_Bio_Med_HWSci_2016.pdfThesis963.6 kBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

605
Last Week
0
Last month
2
checked on Dec 22, 2024

Download(s)

136
checked on Dec 22, 2024

Google ScholarTM

Check


This item is licensed under a Creative Commons License Creative Commons